Abnormal placentation: Evidence-based diagnosis and management of placenta previa, placenta accreta, and vasa previa

Obstetrical and Gynecological Survey

Volumn 67, Issue 8, 2012, Pages 503-519

  Rao, Kiran Prabhaker ^a   Belogolovkin, Victoria ^a   Yankowitz, Jerome ^a   Spinnato II, Joseph A ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ANTEPARTUM HEMORRHAGE; CESAREAN SECTION; DOPPLER FLOWMETRY; EVIDENCE BASED MEDICINE; HUMAN; INCIDENCE; INDUCED ABORTION; PATHOPHYSIOLOGY; PLACENTA ACCRETA; PLACENTA PREVIA; PRENATAL DIAGNOSIS; REVIEW; RISK FACTOR; SPONTANEOUS ABORTION; VASA PREVIA;

CESAREAN SECTION; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYSTERECTOMY; PLACENTA ACCRETA; PLACENTA PREVIA; PREGNANCY; PRENATAL CARE; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL; VASA PREVIA;

EID: 84866317270     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e3182685870     Document Type: Review

References (198)

1. Crane JM, van den Hof MC, Dodds L, et al. Neonatal outcomes with placenta previa. Obstet Gynecol. 1999;93:541-544. (Pubitemid 29147073)
2. Oyelese KO, Turner M, Lees C, et al. Vasa previa: an avoidable obstetric tragedy. Obstet Gynecol Surv. 1999;54:138-145. (Pubitemid 29062039)
3. Bateman BT, Mhyre JM, Callaghan WM. Peripartum hysterectomy in the United States: nationwide 14-year experience. Am J Obstet Gynecol. 2012;206:e1-8.
4. Flood KM, Said S, Geary M. Changing trends in peripartum hysterectomy over the past4decades. Am JObstet Gynecol. 2009;200:632-636.
5. Hudon L, Belfort MA, Broome DR. Diagnosis and management of placenta percreta: a review. Obstet Gynecol Surv. 1998;53:509-517. (Pubitemid 28366878)
6. O'Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol. 1996;175:1632-1638. (Pubitemid 27021039)
7. Oppenheimer LW, Farine D, Richie JW. What is a low-lying placenta? Am J Obstet Gynecol. 1991;165:1036-1038.
8. Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. 2006;107:927-941.
9. Iyasu S, Saftlas AK, Rowley DL, et al. The epidemiology of placenta previa in the United States, 1979 through 1987. Am J Obstet Gynecol. 1993;168:1424-1429. (Pubitemid 23153283)
10. Wexler P, Gottesfeld KR. Early diagnosis of placenta previa. Obstet Gynecol. 1979;54:231-234. (Pubitemid 9206158)
11. Frederiksen MC, Glassenberg R, Stika CS. Placenta previa: a 22-year analysis. Am J Obstet Gynecol. 1999;180:1432-1437. (Pubitemid 29293264)
12. Faiz AS, Ananth CV. Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies. J Matern Fetal Neonatal Med. 2003;13:175-190. (Pubitemid 36384518)
13. Hemminki E, Meriläinen J. Long-term effects of cesarean sections: ectopic pregnancies and placental problems. Am J Obstet Gynecol. 1996;174:1569-1574. (Pubitemid 26165280)
14. Getahun D, Oyelese Y, Salihu HM, et al. Previous cesarean delivery and risks of placenta previa and placenta abruption. Obstet Gynecol. 2006;107:771-778.
15. Hershkowitz R, Fraser D, Mazor M, et al. One or multiple previous cesarean sections are associated with similar increased frequency of placenta previa. Eur J Obstet Gynecol Reprod Biol. 1995;62:185-188.
16. Monica G, Lilja C. Placenta previa, maternal smoking and recurrence risk. Acta Obstet Gynecol Scand. 1995;74: 341-345.
17. Ananth CV, Savitz DA, Luther ER. Maternal cigarette smoking as a risk factor for placental abruption, placenta previa, and uterine bleeding in pregnancy. Am J Epidemiol. 1996;144: 881-889. (Pubitemid 26374957)
18. Williams MA, Mittendorf R. Increasing maternal age as a determinant of placenta previa. More important than increasing parity? J Reprod Med. 1993;38:425-428. (Pubitemid 23178811)
19. Handler AS, Mason ED, Rosenberg DL, et al. The relationship between exposure during pregnancy to cigarette smoking and cocaine use and placenta previa. Am J Obstet Gynecol. 1994;170:884-889. (Pubitemid 24224719)
20. Chelmow D, Andrew DE, Baker ER. Maternal cigarette smoking and placenta previa. Obstet Gynecol. 1996;87:703-706. (Pubitemid 26127086)
21. Taylor VM, Kramer MD, Vaughan TL, et al. Placenta previa and prior cesarean delivery: how strong is the association? Obstet Gynecol. 1994;84:55-57. (Pubitemid 24202956)
22. Obed JY, Adewole IF. Antepartum hemorrhage: the influence of first trimester uterine bleeding. West Afr J Med. 1997;16: 24-26.
23. Spinillo A, Fazzi E, Stronati M, et al. Early morbidity and neuro-developmental outcome in low-birthweight infants born after third trimester bleeding. Am J Perinatol. 1994;11:85-90. (Pubitemid 24109160)
24. Li DK, Wi S. Maternal placental abnormality and the risk of sudden infant death syndrome. Am J Epidemiol. 1999;149: 608-611. (Pubitemid 29162709)
25. Hull AD, Resnik R. Placenta previa, placenta accreta, abruptio placentae, and vasa previa. In: Creasy RK, Resnik R, Iams JD, et al, eds. Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice. 6th ed. Philadelphia, PA: Saunders; 2008:725-737.
26. Ghi T, Contro E, Martina T, et al. Cervical length and risk of antepartum bleeding in women with complete placenta previa. Ultrasound Obstet Gynecol. 2009;33:209-212.
27. Stafford IA, Dashe JS, Shivvers SA, et al. Ultrasonographic cervical length and risk of hemorrhage in pregnancies with placenta previa. Obstet Gynecol. 2010;116:595-600.
28. Zaitoun MM, El Behery MM, Abd El Hameed AA, et al. Does cervical length and the lower placental edge thickness measurement correlates with clinical outcome in cases of complete placenta previa? Arch Gynecol Obstet. 2010.
29. Saitoh M, Ishihara K, Sekiya T, et al. Anticipation of uterine bleeding in placenta previa based on vaginal sonographic evaluation. Gynecol Obstet Invest. 2002;54:37-42.
30. Hasegawa J, Higashi M, Takahashi S, et al. Can ultraso-nography of the placenta previa predict antenatal bleeding? J Clin Ultrasound. 2011.
31. Timor-Tritsch IE, Yunis RA. Confirming the safety of transvaginal sonography in patients suspected of placenta previa. Obstet Gynecol. 1993;81:742-744. (Pubitemid 23137247)
32. Hertzberg BS, Bowie JD, Carroll BA, et al. Diagnosis of placenta previa during the third trimester: role of transperineal sonography. AJR Am J Roentgenol. 1992;159:83-87.
33. Smith RS, Lauria MR, Comstock CH, et al. Transvaginal sonography for all placentas that appear to be low-lying or over the internal cervical os. Ultrasound Obstet Gynecol. 1997;9:22-24. (Pubitemid 27160621)
34. Becker RH, Vonk R, Mende BC, et al. The relevance of placental location at 20-23 gestational weeks for prediction of placenta previa at delivery: evaluation of 8650 cases. Ultrasound Obstet Gynecol. 2001;17:496-501. (Pubitemid 32575098)
35. Dashe JS, McIntire DD, Ramus RM, et al. Persistence of placenta previa according to gestational age at ultrasound detection. Obstet Gynecol. 2002;99:692-697. (Pubitemid 34442442)
36. Taipale P, Hiilesmaa V, Ylotstalo P. Transvaginal ultrasonog-raphy at 18-23 weeks in predicting placenta previa at delivery. Ultrasound Obstet Gynecol. 1998;12:422-425. (Pubitemid 29034211)
37. Lauria MR, Smith RS, Treadwell MC, et al. The use of second-trimester transvaginal sonography to predict placenta previa. Ultrasound Obstet Gynecol. 1996;8:337-340. (Pubitemid 126720621)
38. Ghourab S. Third-trimester transvaginal ultrasonography in placenta previa: does the shape of the lower placental edge predict clinical outcome? Ultrasound Obstet Gynecol. 2001;18:103-108. (Pubitemid 32747672)
39. Oyelese Y. Placenta previa: the evolving role of ultrasound. Ultrasound Obstet Gynecol. 2009;34:123-126.
40. Brenner WE, Edelman DA, Hendricks CH. Characteristics of patients with placenta previa and results of "expectant management." Am J Obstet Gynecol. 1978;132:180-191. (Pubitemid 8398352)
41. Cotton DB, Read JA, Paul RH, et al. The conservative aggressive management of placenta previa. Am J Obstet Gynecol. 1980;137:687-695. (Pubitemid 10035908)
42. Silver R, Depp R, Sabbagha RE, et al. Placenta previa: aggressive expectant management. Am J Obstet Gynecol. 1984;150:15-22. (Pubitemid 14074593)
43. Sharma A, Suri V, Gupta I. Tocolytic therapy in conservative management of symptomatic placenta previa. Int J Gynaecol Obstet. 2004;84:109-113. (Pubitemid 38210002)
44. Besinger RE, Moniak CW, Paskiewicz LS, et al. The effect of tocolytics use in the management of symptomatic placenta previa. Am J Obstet Gynecol. 1995;172:1770-1778.
45. Towers CV, Pircon RA, Heppard M. Is tocolysis safe in the management of third trimester bleeding? Am J Obstet Gynecol. 1999;180:1572-1578. (Pubitemid 29293286)
46. Wing DA, Paul RH, Millar LK. Management of the symptomatic placenta previa: a randomized, controlled trial of in-patient versus outpatient expectant management. Am J Obstet Gynecol. 1996;175:806-811. (Pubitemid 26357933)
47. Love CDB, Fernando KJ, Sargent L, et al. Major placenta previa should not preclude out-patient management. Eur J Obstet Gynecol Reprod Biol. 2004;117:24-29. (Pubitemid 39341174)
48. Arias F. Cervical cerclage for the temporary treatment of patients with placenta previa. Obstet Gynecol. 1988;71:545-548. (Pubitemid 18097638)
49. Cobo E, Conde-Agudelo A, Delgado J, et al. Cervical cer-clage: an alternative for the management of placenta previa? Am J Obstet Gynecol. 1998;179:122-125. (Pubitemid 28394484)
50. Bhide A, Prefumo F, Moore J, et al. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia. BJOG. 2003;110:860-864. (Pubitemid 37159273)
51. Dawson WB, Dumas MD, Romano WM, et al. Translabial ultrasonography and placenta previa: does measurement of the os-placenta distance predict outcome? J Ultrasound Med. 1996;15:441-446. (Pubitemid 26161170)
52. Vergani P, Ornaghi S, Pozzi I, et al. Placenta previa: distance to internal os and mode of delivery. Am J Obstet Gynecol. 2009;201:266.e1-266.e5.
53. Bronsteen R, Valice R, Lee W, et al. Effect of a low-lying placenta on delivery outcome. Ultrasound Obstet Gynecol. 2009;33:204-208.
54. Royal College of Obstetricians and Gynaecologists (RCOG). Placenta Praevia and Placenta Praevia Accreta: Diagnosis and Management. London, UK: Royal College of Obstetricians and Gynaecologists; 2005:12. Green-top Guideline No. 27.
55. Boehm FH, Fleischer AC, Barrett JM. Sonographic placental localization in the determination of the site of uterine incision for placenta previa. J Ultrasound Med. 1982;1:311-314. (Pubitemid 13199805)
56. Hong JY, Jee YS, Yoon HJ, et al. Comparison of general and epidural anesthesia in elective cesarean section for placenta previa totalis: maternal hemodynamics, blood loss and neonatal outcome. Int J Obstet Anesth. 2003;12:12-16.
57. Nelson WL, O'Brien JM. The uterine sandwich for persistent uterine atony: combining the B-Lynch compression suture and an intrauterine Bakri balloon. Am J Obstet Gynecol. 2007;196:e9-10.
58. Cho JH, Jun HS, Lee CN. Hemostatic suturing technique for uterine bleeding during cesarean delivery. Obstet Gynecol. 2000;96:129-131. (Pubitemid 30336294)
59. Arduini M, Epicoco G, Clerici G, et al. B-Lynch suture, intra-uterine balloon, and endouterine hemostatic suture for the management of postpartum hemorrhage due to placenta previa accreta. Int J Gynaecol Obstet. 2010;108:191-193.
60. Al-Harbi NA, Al-Abra ES, Alabbad NS. Utero-vaginal packing. Seven years review in the management of postpartum hemorrhage due to placenta previa/accreta at a maternity hospital in Central Saudi Arabia. Saudi Med J. 2009;30:243-246.
61. Ge J, Liao H, Duan L, et al. Uterine packing during cesarean section in the management of intractable hemorrhage in central placenta previa. Arch Gynecol Obstet. 2012;285:285-289.
62. Law LW, Chor CM, Leung TY. Use of hemostatic gel in postpartum hemorrhage due to placenta previa. Obstet Gynecol. 2010;116:528-530.
63. Zlatnik MG, Little SE, Kohli P, et al. When should women with placenta previa be delivered? A decision analysis. J Reprod Med. 2010;55:373-381.
64. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol. 1997;177:210-214. (Pubitemid 27327336)
65. Habek D, Becareviç R. Emergency peripartum hysterectomy in a tertiary obstetric center: 8-year evaluation. Fetal Diagn Ther. 2007;22:139-142.
66. Rahman J, Al-Ali M, Qutub HO, et al. Emergency obstetric hysterectomy in a university hospital: a 25-year review. J Obstet Gynaecol. 2008;28:69-72. (Pubitemid 351220624)
67. Glaze S, Ekwalanga P, Roberts G, et al. Peripartum hysterectomy: 1999 to 2006. Obstet Gynecol. 2008;111:732-738.
68. Wong HS, Zuccollo J, Tait J, Pringle K. Antenatal topographical assessment of placenta accreta with ultrasound. Aust N Z J Obstet Gynaecol. 2008;48:421-423.
69. Warshak CR, Ramos GA, Eskander R, et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010;115:65-69.
70. Warshak CR, Eskander R, Hull AD, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol. 2006;108: 573-581. (Pubitemid 44337098)
71. Clark SL, Koonings PP, Phelan JP. Placenta previa/accreta and prior cesarean section. Obstet Gynecol. 1985;66:89-92. (Pubitemid 15047391)
72. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005;192: 1458-1461.
73. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2007. Natl Vital Stat Rep. 2010;58:1-85.
74. To WW, Leung WC. Placenta previa and previous cesarean section. Int J Gynaecol Obstet. 1995;51:25-31.
75. Silver RM, Landon MB, Rouse DJ, et alNational Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006;107:1226-1232.
76. You WB, Zahn CM. Postpartum hemorrhage: abnormally adherent placenta, uterine inversion, and puerperal hemato-mas. Clin Obstet Gynecol. 2006;49:184-197. (Pubitemid 44366171)
77. Wax JR, Seiler A, Horowitz S, et al. Interpregnancy interval as a risk factor for placenta accreta. Conn Med. 2000;64: 659-661.
78. Blanc J, Courbiere B, Desbriere R, et al. Is uterine-sparing surgical management of persistent postpartum hemorrhage truly a fertility-sparing technique? Fertil Steril. 2011;95: 2503-2506.
79. Esh-Broder E, Ariel I, Abas-Bashir N, et al. Placenta accreta is associated with IVF pregnancies: a retrospective chart review. BJOG. 2011;118:1084-1089.
80. Hare AA, Olah KS. Pregnancy following endometrial ablation: a review article. J Obstet Gynaecol. 2005;25:108-114. (Pubitemid 43323020)
81. Patni S, ElGarib AM, Majd HS, et al. Endometrial resection mandates reliable contraception thereafterVa case report of placenta increta following endometrial ablation. Eur J Contracept Reprod Health Care. 2008;13:208-211. (Pubitemid 352000655)
82. Hamar BD, Wolff EF, Kodaman PH, et al. Premature rupture of membranes, placenta increta, and hysterectomy in a pregnancy following endometrial ablation. J Perinatol. 2006; 26:135-137.
83. Cook JR, Seman EI. Pregnancy following endometrial ablation: case history and literature review. Obstet Gynecol Surv. 2003;58:551-556. (Pubitemid 36927815)
84. Norwitz ER, Stern HM, Grier H, Lee-Parritz A. Placenta percreta and uterine rupture associated with prior whole body radiation therapy. Obstet Gynecol. 2001;98:929-931. (Pubitemid 33042508)
85. Goshen R, Ariel I, Shuster S, et al. Hyaluronan, CD44 and its variant exons in human trophoblast invasion and placental angiogenesis. Mol Hum Reprod. 1996;2:685-691. (Pubitemid 126717517)
86. Tseng JJ, Chou MM, Hsieh YT, et al. Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accreta. Placenta. 2006;27:70-78. (Pubitemid 41662882)
87. Li M, Yee D, Magnuson TR, et al. Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice. J Clin Invest. 2006;116:2653-2662. (Pubitemid 44511629)
88. Aggarwal P, Gill-Randall R, Wheatley T, et al. Identification of mtDNA mutation in a pedigree with gestational diabetes, deafness, Wolff-Parkinson- White syndrome and placenta accreta. Hum Hered. 2001;51:114-116.
89. Publications Committee, Society for Maternal-Fetal Medicine, Belfort MA. Placenta accreta. Am J Obstet Gynecol. 2010;203:430-439.
90. Styron AG, George RB, Allen TK, et al. Multidisciplinary management of placenta percreta complicated by embolic phenomena. Int J Obstet Anesth. 2008;17:262-266.
91. Mathelier AC, Karachorlu K. Placenta previa and accreta complicated by amniotic fluid embolism. Int J Fertil Womens Med. 2006;51:28-32.
92. Sihler KC, Napolitano LM. Complications of massive transfusion. Chest. 2010;137:209-220.
93. Rosen T. Placenta accreta and cesarean scar pregnancy: overlooked costs of the rising cesarean section rate. Clin Perinatol. 2008;5:519-529.
94. Chen CH, Wang PH, Lin JY, et al. Uterine rupture secondary to placenta percreta in a near-term pregnant woman with a history of hysterotomy. J Obstet Gynaecol Res. 2011;37: 71-74.
95. Wang LM, Wang PH, Chen CL, et al. Uterine preservation in a woman with spontaneous uterine rupture secondary to placenta percreta on the posterior wall: a case report. J Obstet Gynaecol Res. 2009;35:379-384.
96. Kwee A, Bots ML, Visser GH, et al. Emergency peripartum hysterectomy: a prospective study in the Netherlands. Eur J Obstet Gynecol Reprod Biol. 2006;124:187-192. (Pubitemid 43143076)
97. Comstock CH. Antenatal diagnosis of placenta accreta: a review. Ultrasound Obstet Gynecol. 2005;26:89-96. (Pubitemid 41537019)
98. Chou MM, Tseng JJ, Ho ES, et al. Three-dimensional color power Doppler imaging in the assessment of uteroplacental neovascularization in placenta previa increta/percreta. Am J Obstet Gynecol. 2001;185:1257-1260. (Pubitemid 33097397)
99. Dwyer BK, Belogolovkin V, Tran L, et al. Prenatal diagnosis of placenta accreta: sonography or magnetic resonance imaging? J Ultrasound Med. 2008;27:1275-1281.
100. Royal College of Obstetricians and Gynaecologists (RCOG). Placenta Praevia, Placenta Praevia Accreta and Vasa Praevia: Diagnosis and Management. London, UK: Royal College of Obstetricians and Gynaecologists; 2005:26. Green-top Guideline No. 27. 2011:26.
101. Shih JC, Palacios Jaraquemada JM, Su YN, et al. Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: comparison with gray-scale and color Doppler techniques. Ultrasound Obstet Gynecol. 2009;33: 193-203.
102. Hull AD, Resnik R. Placenta accreta and postpartum hemorrhage. Clin Obstet Gynecol. 2010;53:228-236.
103. Lax A, Prince MR, Mennitt KW, et al. The value of specific MRI features in the evaluation of suspected placental invasion. Magn Reson Imaging. 2007;25:87-93. (Pubitemid 46048944)
104. Welsh AW, Ellwood D, Carter J, et al. Opinion: integration of diagnostic and management perspectives for placenta accreta. Aust N Z J Obstet Gynecol. 2009;49:578-587.
105. Comstock CH, Love JJ Jr, Bronsteen RA, et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol. 2004;190: 1135-1140. (Pubitemid 38561537)
106. Levine D, Hulka CA, Ludmir J, et al. Placenta accreta: evaluation with color Doppler US, power Doppler US, and MR imaging. Radiology. 1997;205:773-776. (Pubitemid 27516714)
107. Twickler DM, Lucas MJ, Balis AB, et al. Color flow mapping for myometrial invasion in women with a prior cesarean delivery. J Matern Fetal Med. 2000;9:330-335. (Pubitemid 32141325)
108. Zelop C, Nadel A, Frigoletto FD Jr, et al. Placenta accreta/percreta/ increta: a cause of elevated maternal serum alpha-fetoprotein. Obstet Gynecol. 1992;80:693-694.
109. Hung TH, Shau WY, Hsieh CC, et al. Risk factors for placenta accreta. Obstet Gynecol. 1999;93:545-550.
110. Simonazzi G, Farina A, Curti A, et al. Higher circulating mRNA levels of placental specific genes in a patient with placenta accreta. Prenat Diagn. 2011;31:827-829.
111. Comstock CH. The antenatal diagnosis of placental attachment disorders. Curr Opin Obstet Gynecol. 2011;23:117-122.
112. Balkanli-Kaplan P, Gucer F, Oz-Puyan F, et al. Placenta percreta diagnosed after first-trimester pregnancy termination: a case report. J Reprod Med. 2006;51:662-664. (Pubitemid 44300080)
113. Ju W, Kim SC. Placenta increta after first-trimester dilatation and curettage manifesting as an unusual uterine mass: magnetic resonance findings. Acta Radiol. 2007;48:938-940. (Pubitemid 47551935)
114. Usta IM, Hobeika EM, Musa AA, et al. Placenta previa-accreta: risk factors and complications. Am J Obstet Gyne-col. 2005;193:1045-1049. (Pubitemid 41285492)
115. Harper LM, Odibo AO, Macones GA, et al. Effect of placenta previa on fetal growth. Am J Obstet Gynecol. 2010;203: 330.e1-330.e5.
116. Robinson BK, Grobman WA. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol. 2010;116:835-842.
117. Pacheco LD, Gei AF. Controversies in the management of placenta accreta. Obstet Gynecol Clin North Am. 2011;38: 313-322.
118. Ng MK, Jack GS, Bolton DM, Lawrentschuk N. Placenta percreta with urinary tract involvement: the case for a multi-disciplinary approach. Urology. 2009;74:778-782.
119. Hoffman MS, Karlnoski RA, Mangar D, et al. Morbidity associated with nonemergent hysterectomy for placenta accreta. Am J Obstet Gynecol. 2010;202:628.e1-628.e5.
120. Eller AG, Bennett MA, Sharshiner M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol. 2011;117:331-337.
121. Russo M, Krenz EI, Hart SR, et al. Multidisciplinary approach to the management of placenta accreta. Ochsner J. 2011;11: 84-88.
122. Angstmann T, Gard G, Harrington T, et al. Surgical management of placenta accreta: a cohort series and suggested approach. Am J Obstet Gynecol. 2010;202:38.e1-38.e9.
123. Stotler B, Padmanabhan A, Devine P, et al. Transfusion requirements in obstetric patients with placenta accreta. Transfusion. 2011;51:2627-2633.
124. Snegovskikh D, Clebone A, Norwitz E. Anesthetic management of patients with placenta accreta and resuscitation strategies for associated massive hemorrhage. Curr Opin Anaesthesiol. 2011;24:274-281.
125. Eller AG, Porter TF, Soisson P, et al. Optimal management strategies for placenta accreta. BJOG. 2009;116:648-654.
126. ACOG Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin No. 104: antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol. 2009;113:1180-1189.
127. Bodner LJ, Nosher JL, Gribbin C, et al. Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta. Cardiovasc Intervent Radiol. 2006;29:354-361.
128. Zacharias N, Gei AF, Suarez V, et al. Balloon tip catheter occlusion of the hypogastric arteries for the management of placenta accreta. Am J Obstet Gynecol. 2003;189:S128.
129. Tan CH, Tay KH, Sheah K, et al. Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta. AJR Am J Roentgenol. 2007;189: 1158-1163. (Pubitemid 350033008)
130. Carnevale FC, Kondo MM, de Oliveira Sousa W Jr, et al. Peri-operative temporary occlusion of the internal iliac arteries as prophylaxis in cesarean section at risk of hemorrhage in placenta accreta. Cardiovasc Intervent Radiol. 2011;34:758-764.
131. Jeffrey A, Clark V. The anaesthetic management of caesar-ean section in the interventional radiology suite. Curr Opin Anaesthesiol. 2011;24:439-444.
132. Greenberg JI, Suliman A, Iranpour P, Angle N. Prophylactic balloon occlusion of the internal iliac arteries to treat abnormal placentation: a cautionary case. Am J Obstet Gynecol. 2007; 197:470.e1-470.e4.
133. Bishop S, Butler K, Monaghan S, et al. Multiple complications following the use of prophylactic internal iliac artery balloon catheterisation in a patient with placenta percreta. Int J Obstet Anesth. 2011;20:70-73.
134. Lee JS, Shepherd SM. Endovascular treatment of postpartum hemorrhage. Clin Obstet Gynecol. 2010;53:209-218.
135. O'Rourke N, McElrath T, Baum R, et al. Cesarean delivery in the interventional radiology suite: a novel approach to obstetric hemostasis. Anesth Analg. 2007;104:1193-1194. (Pubitemid 46649944)
136. Kodali BS. Bloodless trilogy? Anesthesia, obstetrics and interventional radiology for cesarean delivery. Int J Obstet Anesth. 2010;19:131-132.
137. Murata H, Hara T, Sumikawa K. Anesthesia for cesarean hysterectomy in a parturient with placenta accreta [in Japanese]. Masui. 2009;58:903-906.
138. Parva M, Chamchad D, Keegan J, et al. Placenta percreta with invasion of the bladder wall: management with a multi-disciplinary approach. J Clin Anesth. 2010;22:209-212.
139. Wise A, Clark V. Strategies to manage major obstetric haemorrhage. Curr Opin Anaesthesiol. 2008;21:281-287. (Pubitemid 351658922)
140. Kato R, Terui K, Yokota K, et al. Anesthetic management for cases of placenta accreta presented for cesarean section: a 7-year single-center experience [in Japanese]. Masui. 2008; 57:1421-1426.
141. Kuczkowski KM. Anesthesia for the repeat cesarean section in the parturient with abnormal placentation: what does an obstetrician need to know? Arch Gynecol Obstet. 2006;273: 319-321.
142. Palacios Jaraquemada JM, Pesaresi M, Nassif JC, et al. Anterior placenta percreta: surgical approach, hemostasis and uterine repair. Acta Obstet Gynecol Scand. 2004;83: 738-744. (Pubitemid 39062148)
143. Gungor T, Simsek A, Ozdemir AO, et al. Surgical treatment of intractable postpartum hemorrhage and changing trends in modern obstetric perspective. Arch Gynecol Obstet. 2009; 280:351-355.
144. Alkazaleh F, Geary M, Kingdom J, et al. Elective non-removal of the placenta and prophylactic uterine artery embolization postpartum as a diagnostic imaging approach for the management of placenta percreta: a case report. J Obstet Gynae-col Can. 2004;26:743-746.
145. Teo SB, Kanagalingam D, Tan HK, et al. Massive postpartum haemorrhage after uterus-conserving surgery in placenta percreta: the danger of the partial placenta percreta. BJOG. 2008;115:789-792. (Pubitemid 351514569)
146. Cho JH, Jun HS, Lee CN. Haemostatic suturing technique for uterine bleeding during caesarean delivery. Obstet Gynecol. 2000;96:129-131. (Pubitemid 30336294)
147. Ferrazzani S, Guariglia L, Triunfo S, et al. Conservative management of placenta previa-accreta by prophylactic uterine arteries ligation and uterine tamponade. Fetal Diagn Ther. 2009;25:400-403.
148. Pelosi MA 3rd, Pelosi MA. Modified cesarean hysterectomy for placenta previa percreta with bladder invasion: retrovesi-cal lower uterine segment bypass. Obstet Gynecol. 1999;93: 830-833. (Pubitemid 29197910)
149. Plauché WC, Gruich FG, Bourgeois MO. Hysterectomy at the time of cesarean section: analysis of 108 cases. Obstet Gynecol. 1981;58:459-464. (Pubitemid 12232154)
150. Matsubara S, Ohkuchi A, Yashi M, et al. Opening the bladder for cesarean hysterectomy for placenta previa percreta with bladder invasion. J Obstet Gynaecol Res. 2009;35:359-363.
151. Bakri YN, Sundin T. Cystotomy for placenta previa percreta with bladder invasion. Urology. 1992;40:580. (Pubitemid 23003212)
152. Matsubara S. Bladder-opening technique for hysterectomy for placenta previa percreta. Arch Gynecol Obstet. 2011;283: 1427-1428.
153. Brigitte E. Fluid and blood transfusion management in obstetrics. Eur J Anaesthesiol. 2010;27:1031-1035.
154. Gunter OL Jr, Au BK, Isbell JM, et al. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma. 2008;65: 527-534.
155. Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62:307-310.
156. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63:805-813. (Pubitemid 350287298)
157. Duchesne JC, Hunt JP, Wahl G, et al. Review of current blood transfusions strategies in a mature level I trauma center: were we wrong for the last 60 years? J Trauma. 2008;65: 272-276.
158. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248:447-458.
159. Butwick AJ, Hilton G, Riley ET, et al. Non-invasive measurement of hemoglobin during cesarean hysterectomy: a case series. Int J Obstet Anesth. 2011;20:240-245.
160. Catling S. Blood conservation techniques in obstetrics: a UK perspective. Int J Obstet Anesth. 2007;16:241-249. (Pubitemid 46880313)
161. Charbit B. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5:266.
162. Pepas LP, Arif-Adib M, Kadir RA. Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. Obstet Gynecol. 2006;108:757-761. (Pubitemid 44306417)
163. Franchini M. The use of recombinant activated factor VII in platelet disorders: a critical review of the literature. Blood Transfus. 2009;7:24-28.
164. Franchini M, Lippi G. Recombinant activated factor VII: mechanisms of action and current indications. Semin Thromb Hemost. 2010;36:485-492.
165. Phillips LE, McLintock C, Pollock W, et al. Australian and New Zealand Haemostasis Registry. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. Anesth Analg. 2009;109:1908-1915.
166. Waters JH, Biscotti C, Potter PS, et al. Amniotic fluid removal during cell salvage inthe cesarean section patient. Anesthesiol-ogy. 2000;92:1531-1536. (Pubitemid 30412469)
167. Rainaldi MP, Tazzari PL, Scagliarini G, et al. Blood salvage during caesarean section. Br J Anaesth. 1998;80:195-198. (Pubitemid 28069769)
168. Iwama H. Bradykinin-associated reactions in white cell-reduction filter. J Crit Care. 2001;16:74-81. (Pubitemid 32729944)
169. Dildy GA, Scott JR, Saffer CS, et al. An effective pressure pack for severe pelvic hemorrhage. Obstet Gynecol. 2006; 108:1222-1226. (Pubitemid 44665419)
170. van Herwaarden JA, van Vroonhoven TJ. Abdominal packing for surgically uncontrollable hemorrhage in ruptured abdominal aortic aneurysm repair. J Vasc Surg. 2001;33: 195-196. (Pubitemid 32109628)
171. Sentilhes L, Kayem G, Ambroselli C, et al. Fertility and pregnancy outcomes following conservative treatment for placenta accreta. Hum Reprod. 2010;25:2803-2810.
172. Wright JD, Bonanno C, Shah M, et al. Peripartum hysterectomy. Obstet Gynecol. 2010;116:429-434.
173. Timmermans S, van Hof AC, Duvekot JJ. Conservative management of abnormally invasive placentation. Obstet Gynecol Surv. 2007;62:529-539. (Pubitemid 47203383)
174. Kayem G, Clé ment D, Goffinet F. Recurrence following conservative management of placenta accreta. Int J Gynaecol Obstet. 2007;99:142-143. (Pubitemid 47561919)
175. Bretelle F, Courbiere B, Mazouni C, et al. Management of placenta accreta: morbidity and outcome. Eur J Obstet Gynecol Reprod Biol. 2007;133:34-39. (Pubitemid 46970802)
176. Chiang YC, Shih JC, Lee CN. Septic shock after conservative management for placenta accreta. Taiwan J Obstet Gynaecol. 2006;45:64-66.
177. Morgan M, Atalla R. Mifepristone and misoprostol for management of
178. Lee PS, Bakelaar R, Fitpatrick CB, et al. Medical and surgical treatment of placenta percreta to optimize bladder preservation. Obstet Gynecol. 2008;112:421-424.
179. Dueñas-Garcia OF, Diaz-Sotomayor M, Rico-Olvera H. Utility of the pulsatility index of the uterine arteries and human chorionic gonadotropinina series of casesofplacenta accreta. J Obstet Gynaecol Res. 2011;37:1112-1116.
180. Weinstein A, Chandra P, Schiavello H, et al. Conservative management of placenta previa percreta in a Jehovah's Witness. Obstet Gynecol. 2005;105:1247-1250. (Pubitemid 40570993)
181. Esakoff TF, Handler SJ, Granados JM, et al. PAMUS: placenta accreta management across the United States. JMatern Fetal Neonatal Med. 2012;25:761-765.
182. Catanzarite V, Maida C, Thomas W, et al. Prenatal sono-graphic diagnosis of vasa previa: ultrasound findings and obstetric outcome in ten cases. Ultrasound Obstet Gynecol. 2001;18:109-115. (Pubitemid 32747673)
183. Oyelese Y, Catanzarite V, Prefumo F, et al. Vasa previa: the impact of prenatal diagnosis on outcomes. Obstet Gynecol. 2004;103:937-942. (Pubitemid 40458995)
184. Francois K, Mayer S, Harris C, et al. Association of vasa previa at delivery with a history of second-trimester placenta previa. J Reprod Med. 2003;48:771-774. (Pubitemid 37314943)
185. Schachter M, Tovbin Y, Arieli S, et al. In vitro fertilization is a risk factor for vasa previa. Fertil Steril. 2002;78:642-643.
186. Lee W, Kirk JS, Comstock CH, et al. Vasa previa: prenatal detection by three-dimensional ultrasonography. Ultrasound Obstet Gynecol. 2000;16:384-387. (Pubitemid 32154678)
187. Gianopoulos J, Carver T, Tomich P et al. Diagnosis of vasa previa with ultrasonography. Obstet Gynecol. 1987;69: 488-491. (Pubitemid 17025942)
188. Nomiyama M, Toyota Y, Kawano H. Antenatal diagnosis of velamentous umbilical cord insertion and vasa previa with color Doppler imaging. Ultrasound Obstet Gynecol. 1998; 12:426-429. (Pubitemid 29034212)
189. Mabuchi Y, Yamoto M, Minami S, et al. Two cases of vasa previa diagnosed prenatally using three-dimensional ultraso-nography. J Clin Ultrasound. 2010;38:389-392.
190. Kuwata T, Matsubara S, Saito Y, et al. Large vasa previa mimicking a small forebag. J Clin Ultrasound. 2011;39:274-275.
191. Hasegawa J, Nakamura M, Sekizawa A, et al. Prediction of risk for vasa previa at 9-13 weeks' gestation. J Obstet Gynaecol Res. 2011;37:1346-1351.
192. Kikuchi A, Uemura R, Serikawa T, et al. Clinical significances of magnetic resonance imaging in prenatal diagnosis of vasa previa in a woman with bilobed placentas. J Obstet Gynaecol Res. 2011;37:75-78.
193. Antoine C, Young BK, Silverman F, et al. Sinusoidal fetal heart rate pattern with vasa previa in twin pregnancy. J Reprod Med. 1982;27:295-300. (Pubitemid 12086621)
194. Schellpfeffer MA. Improved neonatal outcome of vasa previa with aggressive intrapartum management. A report of two cases. J Reprod Med. 1995;40:327-332.
195. Robinson BK, Grobman WA. Effectiveness of timing strategies for delivery of individuals with vasa previa. Obstet Gyne-col. 2011;117:542-549.
196. Chmait RH, Chavira E, Kontopoulos EV, et al. Third trimester fetoscopic laser ablation of type II vasa previa. J Matern Fetal Neonatal Med. 2010;23:459-462.
197. Quintero RA, Kontopoulos EV, Bornick PW, et al. In utero laser treatment of type II vasa previa. J Matern Fetal Neonatal Med. 2007;20:847-851. (Pubitemid 350207570)
198. Canterino JC, Mondestin-Sorrentino M, Muench MV, et al. Vasa previa: prenatal diagnosis and evaluation with 3-dimensional sonography and power angiography. J Ultrasound Med. 2005; 24:721-724. (Pubitemid 40577689)